Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply | Zendy

AI Assistant Blog Pricing

Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.